<?xml version='1.0' encoding='iso-8859-1' ?>
<documents><document>
<title>Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells</title>
<publication-date>2008-04-01T00:00:00-07:00</publication-date>
<state>published</state>
<authors>
<author>
<institution>University of Tennessee - Knoxville</institution>
<lname>Cekanova</lname>
<fname>Maria</fname>
</author>
<author>
<lname>Li</lname>
<fname>X</fname>
</author>
<author>
<lname>Yuan</lname>
<fname>J</fname>
</author>
<author>
<lname>Kim</lname>
<fname>K</fname>
<mname>B</mname>
</author>
<author>
<email>sbaek2@utk.edu</email>
<institution>The University of Tennessee</institution>
<lname>Baek</lname>
<fname>Seung</fname>
<mname>J</mname>
</author>
</authors>
<keywords>
<keyword>Colorectal Neoplasms</keyword>
<keyword>Gene Expression Profiling</keyword>
<keyword>Regulation</keyword>
<keyword>Neoplastic drug effects</keyword>
<keyword>HCT116 Cells</keyword>
<keyword>Human</keyword>
<keyword>agonists</keyword>
<keyword>PPAR gamma physiology</keyword>
<keyword>Prostaglandin D2</keyword>
<keyword>pharmacology</keyword>
<keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword>
<keyword>Signal Transduction</keyword>
<keyword>Thiazolidinediones</keyword>
<keyword>Transcriptional Activation</keyword>
</keywords>
<disciplines><discipline>Alternative and Complementary Medicine</discipline>
<discipline>Medical Molecular Biology</discipline>
<discipline>Medical Nutrition</discipline>
<discipline>Molecular Biology</discipline>
<discipline>Molecular, Genetic, and Biochemical Nutrition</discipline>
<discipline>Molecular Genetics</discipline>
<discipline>Nutritional and Metabolic Diseases</discipline>
<discipline>Other Pharmacology, Toxicology and Environmental Health</discipline>
</disciplines><abstract>&lt;p&gt;The peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear transcription factor that controls the genes involved in metabolism and carcinogenesis. In the present study, we examined the alteration of gene expression in HCT-116 human colorectal cancer cells by PPARgamma agonists: MCC-555 (5 microM), rosiglitazone (5 microM), and 15-deoxy-Delta12,14-prostaglandin J2 (1 microM). The long-oligo microarray data revealed a list of target genes commonly induced (307 genes) and repressed (32 genes) by tested PPARgamma agonists. These genes were analyzed by Onto-Express software and KEGG pathway analysis and revealed that PPARgamma agonists are involved in cell proliferation, focal adhesion, and several signaling pathways. Eight genes were selected to confirm the microarray data by RT-PCR and real-time PCR, from which CSTA, DAP13, TAF12, RIS1, CDKN3 and MAGOH were up-regulated, and KLHL11 and NCOA2 were down-regulated. This study elucidates the commonly induced genes modulated by tested PPARgamma ligands involved in the different signaling pathways and metabolisms, probably mediated in a PPARgamma-dependent manner in colorectal cancer cells and helps to better understand the pleiotropic actions of PPARgamma ligands.&lt;/p&gt;</abstract>
<fpage>809</fpage>
<lpage>819</lpage>
<coverpage-url>https://trace.tennessee.edu/utk_biocpubs/63</coverpage-url>
<fulltext-url>https://trace.tennessee.edu/cgi/viewcontent.cgi?article=1062&amp;amp;context=utk_biocpubs&amp;amp;unstamped=1</fulltext-url>
<label>63</label>
<document-type>article</document-type>
<type>article</type>
<articleid>1062</articleid>
<submission-date>2010-10-27T11:32:56-07:00</submission-date>
<publication-title>Faculty Publications and Other Works -- Biochemistry, Cellular and Molecular Biology</publication-title>
<context-key>3763623</context-key>
<submission-path>utk_biocpubs/63</submission-path>
<fields>
<field name="create_openurl" type="boolean">
<value>true</value>
</field>
<field name="publication_date" type="date">
<value>2008-04-01T00:00:00-07:00</value>
</field>
<field name="source_publication" type="string">
<value>International Journal of Oncology</value>
</field>
</fields>
</document>
</documents>